Status:
UNKNOWN
Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study
Lead Sponsor:
Yonsei University
Conditions:
Respiratory Insufficiency
Acute Hypercapnic Respiratory Failure
Eligibility:
All Genders
18-100 years
Brief Summary
This study targets adult patients treated with high flow nasal cannula (HFNC) at emergency department (ED) of Severance hospital, Yonsei university. Patients with acute hypoxic respiratory failure pre...
Eligibility Criteria
Inclusion
- Patients with dyspnea and applied to HFNC in ED at Severance Hospital.
Exclusion
- age\<18
- GCS ≤ 12
- Do not resuscitate patients, whom wishes not to included in the study
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06064409
Start Date
November 1 2023
End Date
March 1 2025
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance hospital
Seoul, South Korea